Sponsor Dossier
LEO Pharma
Sponsor Dossier for LEO Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ADVANTAN
- Brand: ANZUPGO
- Brand: DAIVOBET
- Brand: DAIVONEX
- Brand: ENSTILAR
- Brand: FINACEA
- Brand: FUCIDIN
- Brand: KLARVANTA
About
LEO Pharma is an Australian Private Company with ABN 72 147 880 617, registered in Queensland and currently active.
Portfolio
LEO Pharma has 11 brands on the ARTG, of which 9 are indexable and 9 carry a Product Information document. 5 brands are PBS-listed, 4 have a PBAC outcome on record, and 3 have an AusPAR on record. Notable brands include ADVANTAN, ANZUPGO, DAIVOBET, DAIVONEX, ENSTILAR, FINACEA, FUCIDIN, KLARVANTA, SPEVIGO, SUPRIAD, XAMIOL.
Therapeutic focus
— Dermatology: 10 brands — Infectious Disease: 1 brand
PBS footprint
5 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-07-01, across 4 brands with a PBAC outcome on record. The latest AusPAR is 2025-12-22, across 3 brands with an AusPAR on record.